Therefore, we aimed to investigate the PALB2/LP variant prevalence and mutational spectrum in the Hungarian HBOC patients, including 191 very young cases, to compare it to patients with non-HBOC tumor types and to a healthy, non-cancer control population. The gene discussed is PALB2; the disease is cancer.